Core Laboratories INC /DE/ Form 4 insider transactions

Director Curt Anastasio reports acquisition and disposal of Core Laboratories Inc. stock and restricted shares on April 1, 2025.

Director Michael Straughen reports the disposition and acquisition of Core Laboratories Inc. common stock on April 1, 2025, according to a Form 4 filing.

Sow Hang Teo, CAO & Treasurer of Core Laboratories, reports the acquisition of 7,692 performance shares that will vest based on the company's Return on Invested Capital (ROIC) relative to its Bloomberg Peer Group.

Mark Damian Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc., was granted 32,912 performance shares that will vest based on the company's return on invested capital (ROIC) relative to its peer group over a three-year period.

Gwendolyn Gresham, SVP of Core Laboratories, reports the acquisition of 32,912 performance shares tied to the company's Return on Invested Capital (ROIC) relative to its Bloomberg Peer Group.

Christopher Scott Hill, SVP & CFO of Core Laboratories, reports the acquisition of 68,800 performance shares that will vest based on the company's ROIC performance relative to its peer group over a three-year period.

Lawrence Bruno, Chairman and CEO of Core Laboratories Inc., reports the acquisition of 202,764 performance shares tied to the company's Return on Invested Capital (ROIC) relative to its Bloomberg Peer Group.

Lawrence Bruno, Chairman and CEO of Core Laboratories Inc., reports transactions involving common stock and performance shares, resulting in adjustments to his beneficial ownership.

Christopher Scott Hill, SVP & CFO of Core Laboratories, reports transactions involving common stock and performance shares, including the vesting of performance shares based on the company's return on invested capital.

Gwendolyn Gresham, SVP of Core Laboratories, reports the disposition and acquisition of common stock and performance shares on December 31, 2024.

Mark Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc., reports transactions involving common stock and performance shares, including vesting of performance shares based on return on invested capital.

A Form 4 filing reveals that Core Laboratories Inc.'s CAO & Treasurer, Teo Sow Hang, engaged in stock transactions involving the acquisition and disposal of common stock and restricted shares.

Sow Hang Teo, CAO & Treasurer of Core Laboratories, reports the acquisition and disposal of common stock and restricted shares on October 1, 2024.

Mark Damian Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc., executed stock options and disposed of shares to cover tax obligations on October 1, 2024.

Mark Damian Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc., reports transactions involving common stock, including the exercise of restricted shares and subsequent disposal to cover tax obligations.

Sow Hang Teo, CAO & Treasurer of Core Laboratories, reports multiple transactions involving common stock and restricted shares on August 1, 2024.

Sow Hang Teo, CAO & Treasurer of Core Laboratories Inc., reports acquisition and disposal of common stock and derivative securities.

Mark Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc., reports acquisition and disposal of common stock and restricted shares on May 1, 2024.

Sow Hang Teo, CAO & Treasurer of Core Laboratories Inc., reports the acquisition of 6,662 performance shares on April 9, 2024, contingent on performance criteria related to Return On Invested Capital (ROIC) within a three-year performance period.

Director Temeng Kwaku reports acquisition and disposal of Core Laboratories Inc. common stock and restricted shares on April 1, 2024.

Director Michael Straughen of Core Laboratories reports acquisition and disposal of common stock and restricted shares on April 1, 2024.

Director Katherine Murray reports acquisition and disposal of Core Laboratories Inc. common stock and restricted shares on April 1, 2024.

Director Harvey Robert Klingensmith reports acquisition and disposal of Core Laboratories Inc. common stock and restricted shares on April 1, 2024.

Director Martha Z. Carnes reports acquisition and disposal of Core Laboratories Inc. common stock and restricted shares on April 1, 2024.

Director Curt Anastasio reports acquisition and disposal of Core Laboratories Inc. common stock and restricted shares on April 1, 2024.